Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MGRM Stock Forecast 2026-2027
$6.00
Current Price
$244.21M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MGRM Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MGRM Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+5.8%
1 Year Change
0.0%
Year-to-Date Change
-2.1%
From 52W High of $6.13
+212.8%
From 52W Low of $1.92
📊 TOP ANALYST CALLS
Did MGRM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Monogram Orthopaedics is one of their latest high-conviction picks.
Latest MGRM Stock Price Targets & Analyst Predictions
MGRM has shown a year-to-date change of 0.0% and a 1-year change of 5.8%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MGRM. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MGRM Analyst Ratings
0
Buy
0
Hold
0
Sell
MGRM Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $6.00
Latest MGRM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MGRM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 18, 2025 | Roth MKM | Jason Wittes | Buy | Maintains | $5.40 |
| Dec 9, 2024 | Roth MKM | Jason Wittes | Buy | Initiates | $4.00 |
Monogram Technologies Inc. (MGRM) Competitors
The following stocks are similar to Monogram Orthopaedics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
MGRM
Monogram Orthopaedics
mkt cap
244.21M
Monogram Technologies Inc. (MGRM) Financial Data
Monogram Technologies Inc. has a market capitalization of $244.21M with a P/E ratio of -13.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -228.8%.
Valuation Metrics
Market Cap
$244.21M
Enterprise Value
$231.23M
P/E Ratio
-13.0x
PEG Ratio
-0.3x
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+5.3%
Current Ratio
2.2x
Debt/Equity
3.4x
ROE
-228.8%
ROA
-72.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Monogram Technologies Inc. (MGRM) Business Model
About Monogram Technologies Inc.
What They Do
Develops advanced manufacturing technologies.
Business Model
Monogram Technologies Inc. generates revenue by providing innovative manufacturing solutions, including additive manufacturing systems and digital design software, to various industries like aerospace, automotive, and healthcare. Their business model relies on the integration of technology with traditional manufacturing processes, which enhances efficiency and reduces waste, thereby attracting clients looking for precision and innovation.
Additional Information
The company is heavily invested in research and development, positioning itself as a leader in smart manufacturing. This strategic focus not only supports its growth but also helps clients adapt to new production methods on a global scale.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
27
CEO
Mr. Benjamin Sexson C.F.A.
Country
United States
IPO Year
2023
Website
www.monogramtechnologies.comMonogram Technologies Inc. (MGRM) Latest News & Analysis
Latest News
Quick Summary
Monogram Technologies Inc. (NASDAQ:MGRM) will hold a shareholder/analyst call on September 30, 2025, at 1:00 PM EDT, featuring Chairman and CEO Benjamin Sexson.
Why It Matters
The shareholder call indicates potential strategic updates and insights on company performance, which can influence stock valuation and investor sentiment for Monogram Technologies.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Zimmer Biomet reported Q2 net sales of $2.077 billion, up 7.0%. Diluted EPS was $0.77; adjusted EPS rose 3.0% to $2.07. The company revised 2025 revenue growth guidance to 6.7%-7.7%.
Why It Matters
Strong sales growth and increased earnings per share indicate solid company performance. Tightened revenue guidance suggests management confidence, likely influencing stock valuation positively.
Source: PRNewsWire
Market Sentiment:
Neutral
Monogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
11 months ago
Quick Summary
Monogram Technologies (NASDAQ: MGRM) successfully performed the world's first autonomous robotic knee replacement surgery on a live patient in India on July 26, 2025, as part of a clinical trial.
Why It Matters
Monogram's successful autonomous knee surgery highlights its technological leadership, potentially boosting stock value and attracting investment in AI-driven healthcare innovations.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Monogram Technologies Inc. (MGRM) is set to be sold to Zimmer Biomet Holdings Inc. (ZBH) for $4.04 per share in cash, with additional contingent value rights for shareholders.
Why It Matters
The investigation into Monogram Technologies' sale could affect share prices and investor sentiment, highlighting potential legal risks or changes in the deal's structure.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Zimmer Biomet is acquiring Monogram Technologies for $4.04 per share, valuing the deal at $177 million. The acquisition is expected to be neutral to earnings from 2025-2027 and accretive thereafter.
Why It Matters
The acquisition enhances Zimmer Biomet's product offerings in orthopedic robotics, potentially boosting revenue and earnings growth post-2027, signaling long-term value creation for shareholders.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Wohl & Fruchter LLP is investigating the proposed sale of Monogram Technologies (MGRM) to Zimmer Biomet for $4.04 per share plus contingent value rights potentially worth $12.37 per share.
Why It Matters
The investigation into Monogram's sale could impact its stock price and investor confidence, especially regarding the fairness of the offer and potential future payouts from the CVR.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MGRM Stock
What is Monogram Technologies Inc.'s (MGRM) stock forecast for 2027?
Analyst forecasts for Monogram Technologies Inc. (MGRM) are not currently available. The stock is trading at $6.00.
Is MGRM stock a good investment in 2027?
Analyst ratings for MGRM are not currently available. The stock is currently trading at $6.00. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MGRM stock?
Price predictions from Wall Street analysts for MGRM are not currently available. The stock is trading at $6.00.
What is Monogram Technologies Inc.'s business model?
Monogram Technologies Inc. generates revenue by providing innovative manufacturing solutions, including additive manufacturing systems and digital design software, to various industries like aerospace, automotive, and healthcare. Their business model relies on the integration of technology with traditional manufacturing processes, which enhances efficiency and reduces waste, thereby attracting clients looking for precision and innovation.
What is the highest forecasted price for MGRM Monogram Technologies Inc.?
Price targets from Wall Street analysts for MGRM are not currently available. The stock is trading at $6.00.
What is the lowest forecasted price for MGRM Monogram Technologies Inc.?
Price targets from Wall Street analysts for MGRM are not currently available. The stock is trading at $6.00.
What is the overall MGRM consensus from analysts for Monogram Technologies Inc.?
Analyst ratings for MGRM are not currently available. The stock is trading at $6.00.
How accurate are MGRM stock price projections?
Stock price projections, including those for Monogram Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 16, 2026 10:07 AM UTC